ARSENIC

ARSENIC was reported 2307 times

ARSENIC is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLOOD ARSENIC INCREASED 2 0.0370
1 RIGHT VENTRICULAR SYSTOLIC PRESSURE INCREASED 9 0.0284
2 FAECAL ELASTASE CONCENTRATION DECREASED 1 0.0263
3 CEREBRAL CONGESTION 4 0.0238
4 DIFFERENTIATION SYNDROME 8 0.0109
5 HAEMATOPOIETIC NEOPLASM 2 0.0106
6 METAL POISONING 4 0.0069
7 ISCHAEMIC HEPATITIS 9 0.0066
8 CHROMOSOMAL DELETION 1 0.0063
9 HERPES ZOSTER MENINGOENCEPHALITIS 2 0.0056
10 MYXOEDEMA 1 0.0045
11 GRAFT VERSUS HOST DISEASE IN EYE 1 0.0043
12 BONE MARROW NECROSIS 1 0.0043
13 SWEAT GLAND TUMOUR 1 0.0043
14 ENTEROBACTER BACTERAEMIA 1 0.0033
15 ACUTE PROMYELOCYTIC LEUKAEMIA 3 0.0029
16 GASTROINTESTINAL ANGIODYSPLASIA 1 0.0024
17 HYPERLEUKOCYTOSIS 2 0.0023
18 MENINGOENCEPHALITIS HERPETIC 1 0.0022
19 GRAFT VERSUS HOST DISEASE IN LUNG 1 0.0021
20 HYPERAEMIA 4 0.0020
21 OEDEMATOUS PANCREATITIS 1 0.0018
22 VICTIM OF HOMICIDE 1 0.0017
23 HYPOVOLAEMIA 9 0.0015
24 VICTIM OF CHEMICAL SUBMISSION 1 0.0015
25 HAEMOTHORAX 4 0.0014
26 VITAMIN B COMPLEX DEFICIENCY 1 0.0013
27 CONJUNCTIVAL HAEMORRHAGE 5 0.0013
28 TESTICULAR ATROPHY 1 0.0011
29 AXONAL NEUROPATHY 1 0.0011
30 INTESTINAL PSEUDO-OBSTRUCTION 1 0.0011
31 TRICUSPID VALVE INCOMPETENCE 9 0.0011
32 CARDIOPULMONARY FAILURE 4 0.0010
33 CYTOGENETIC ABNORMALITY 1 0.0009
34 MITRAL VALVE INCOMPETENCE 9 0.0008
35 MYELITIS TRANSVERSE 1 0.0007
36 STRONGYLOIDIASIS 1 0.0006
37 LEUKAEMIA RECURRENT 1 0.0006
38 PRODUCT TAMPERING 1 0.0006
39 FLUID OVERLOAD 8 0.0005
40 DIPLEGIA 1 0.0005
41 ACUTE MYELOID LEUKAEMIA RECURRENT 1 0.0005
42 GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0005
43 IDIOPATHIC INTRACRANIAL HYPERTENSION 1 0.0004
44 PERICARDIAL EFFUSION 10 0.0004
45 ARTERIOSCLEROSIS 4 0.0004
46 INFREQUENT BOWEL MOVEMENTS 1 0.0004
47 VENOOCCLUSIVE DISEASE 1 0.0004
48 BRAIN OEDEMA 5 0.0004
49 STEATORRHOEA 1 0.0004
50 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
51 INTRACRANIAL PRESSURE INCREASED 2 0.0004
52 DUODENAL ULCER HAEMORRHAGE 1 0.0003
53 BONE MARROW DISORDER 1 0.0003
54 LEUKAEMIA 3 0.0003
55 EXPOSURE TO TOXIC AGENT 1 0.0003
56 PULMONARY CONGESTION 4 0.0003
57 RENAL INJURY 9 0.0003
58 PARAESTHESIA ORAL 4 0.0003
59 THROMBOCYTOSIS 1 0.0003
60 MYOCARDIAL ISCHAEMIA 3 0.0003
61 OBSTRUCTION 1 0.0003
62 PERIPHERAL ISCHAEMIA 1 0.0002
63 PAPILLOEDEMA 1 0.0002
64 DISEASE COMPLICATION 1 0.0002
65 VENOOCCLUSIVE LIVER DISEASE 1 0.0002
66 HYPERVOLAEMIA 1 0.0002
67 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
68 TOXIC ENCEPHALOPATHY 1 0.0002
69 UPPER RESPIRATORY TRACT INFECTION 9 0.0002
70 ACUTE MYELOID LEUKAEMIA 3 0.0002
71 MALABSORPTION 1 0.0002
72 NORMAL NEWBORN 1 0.0002
73 NONSPECIFIC REACTION 1 0.0002
74 PERICARDITIS 3 0.0002
75 NEUROTOXICITY 3 0.0002
76 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
77 MYOCLONUS 2 0.0002
78 HEPATITIS CHOLESTATIC 1 0.0002
79 NEURALGIA 4 0.0002
80 POISONING 2 0.0002
81 OCCUPATIONAL EXPOSURE TO PRODUCT 1 0.0002
82 HERPES SIMPLEX 1 0.0002
83 PRODUCT PREPARATION ISSUE 1 0.0002
84 ASPERGILLUS INFECTION 1 0.0002
85 ACUTE HEPATIC FAILURE 2 0.0001
86 HYPERTRANSAMINASAEMIA 1 0.0001
87 SINUS TACHYCARDIA 2 0.0001
88 RETINAL HAEMORRHAGE 1 0.0001
89 GRAFT VERSUS HOST DISEASE 1 0.0001
90 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
91 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
92 NASAL DISCOMFORT 1 0.0001
93 COMPLETED SUICIDE 10 0.0001
94 HAEMATEMESIS 3 0.0001
95 PRODUCT CONTAINER ISSUE 1 0.0001
96 THROMBOCYTOPENIA 13 0.0001
97 CARDIAC FAILURE CONGESTIVE 9 0.0001
98 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
99 LOSS OF LIBIDO 1 0.0001
100 OEDEMA 6 0.0001
101 HIDRADENITIS 1 0.0001
102 POISONING DELIBERATE 1 0.0001
103 PRODUCT PACKAGING ISSUE 1 0.0001
104 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
105 HAEMATOCRIT DECREASED 2 0.0001
106 SUBARACHNOID HAEMORRHAGE 1 0.0001
107 PRODUCT ODOUR ABNORMAL 1 0.0001
108 TRANSAMINASES INCREASED 2 0.0001
109 PULMONARY OEDEMA 4 0.0001
110 HAEMATURIA 3 0.0001
111 NEOPLASM 1 0.0001
112 DELIRIUM 3 0.0001
113 ATAXIA 1 0.0001
114 NOCTURIA 1 0.0001
115 ENCEPHALOPATHY 2 0.0001
116 HYPERCALCAEMIA 1 0.0001
117 INJECTION SITE INDURATION 1 0.0001
118 PLATELET COUNT INCREASED 1 0.0001
119 OEDEMA PERIPHERAL 9 0.0001
120 DRUG TOXICITY 1 0.0001
121 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
122 COORDINATION ABNORMAL 1 0.0001
123 LYMPHOPENIA 1 0.0001
124 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
125 HEPATOCELLULAR INJURY 1 0.0001
126 MYELODYSPLASTIC SYNDROME 1 0.0001
127 HAEMORRHAGE INTRACRANIAL 1 0.0001
128 ILL-DEFINED DISORDER 4 0.0001
129 THYROID DISORDER 1 0.0001
130 LUNG INFECTION 1 0.0001
131 CARDIAC ARREST 5 0.0001
132 FACE OEDEMA 1 0.0001
133 CANDIDA INFECTION 1 0.0001
134 CIRCULATORY COLLAPSE 1 0.0001
135 MULTI-ORGAN FAILURE 1 0.0001
136 DRUG INTERACTION 9 0.0001
137 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
138 GOUT 1 0.0001
139 INJECTION SITE MASS 2 0.0001
140 CHOLESTASIS 1 0.0001
141 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
142 CARDIAC FAILURE 4 0.0000
143 INTENTIONAL SELF-INJURY 1 0.0000
144 PRODUCT PREPARATION ERROR 1 0.0000
145 LIVER FUNCTION TEST INCREASED 1 0.0000
146 PANCREATITIS ACUTE 1 0.0000
147 SHOCK 1 0.0000
148 TOXICITY TO VARIOUS AGENTS 7 0.0000
149 OSTEONECROSIS OF JAW 1 0.0000
150 ERECTILE DYSFUNCTION 1 0.0000
151 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
152 FEAR 1 0.0000
153 DISTURBANCE IN ATTENTION 2 0.0000
154 NEUTROPENIA 5 0.0000
155 RESPIRATORY ARREST 1 0.0000
156 RESPIRATORY DISTRESS 1 0.0000
157 PANCYTOPENIA 2 0.0000
158 ASCITES 1 0.0000
159 METABOLIC ACIDOSIS 1 0.0000
160 HYPERHIDROSIS 4 0.0000
161 BLOOD CREATININE INCREASED 2 0.0000
162 GAIT INABILITY 1 0.0000
163 INJURY 2 0.0000
164 HYPOXIA 1 0.0000
165 PNEUMONIA 9 0.0000
166 MYELOSUPPRESSION 1 0.0000
167 C-REACTIVE PROTEIN INCREASED 1 0.0000
168 RESPIRATORY FAILURE 2 0.0000
169 BLINDNESS 1 0.0000
170 DRUG ABUSE 2 0.0000
171 SEPTIC SHOCK 1 0.0000
172 MENTAL DISORDER 1 0.0000
173 MYOCARDIAL INFARCTION 4 0.0000
174 TACHYCARDIA 2 0.0000
175 ADVERSE DRUG REACTION 2 0.0000
176 THERAPY NON-RESPONDER 1 0.0000
177 MUSCLE SPASMS 4 0.0000
178 COGNITIVE DISORDER 1 0.0000
179 ARRHYTHMIA 1 0.0000
180 ANAEMIA 4 0.0000
181 LEUKOPENIA 1 0.0000
182 PLATELET COUNT DECREASED 2 0.0000
183 DIARRHOEA 12 0.0000
184 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
185 TREMOR 3 0.0000
186 MEDICATION ERROR 1 0.0000
187 HERPES ZOSTER 1 0.0000
188 SEIZURE 2 0.0000
189 COVID-19 3 0.0000
190 DISEASE PROGRESSION 2 0.0000
191 PLEURAL EFFUSION 1 0.0000
192 FEELING HOT 1 0.0000
193 FATIGUE 12 0.0000
194 AMNESIA 1 0.0000
195 INFUSION RELATED REACTION 1 0.0000
196 FEBRILE NEUTROPENIA 1 0.0000
197 RENAL FAILURE 2 0.0000
198 NEOPLASM MALIGNANT 1 0.0000
199 SOMNOLENCE 3 0.0000
200 SLEEP DISORDER 1 0.0000
201 HYPOAESTHESIA 2 0.0000
202 ACNE 1 0.0000
203 DIABETES MELLITUS 1 0.0000
204 BLOOD PRESSURE INCREASED 2 0.0000
205 PARAESTHESIA 2 0.0000
206 INJECTION SITE HAEMORRHAGE 1 0.0000
207 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
208 INTENTIONAL PRODUCT MISUSE 1 0.0000
209 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
210 HEADACHE 7 0.0000
211 VOMITING 5 0.0000
212 NEUROPATHY PERIPHERAL 1 0.0000
213 HYPOTENSION 2 0.0000
214 FLUSHING 1 0.0000
215 CHEST DISCOMFORT 1 0.0000
216 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
217 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
218 CONSTIPATION 2 0.0000
219 MUSCULAR WEAKNESS 1 0.0000
220 INCORRECT DOSE ADMINISTERED 2 0.0000
221 FEELING ABNORMAL 2 0.0000
222 JOINT SWELLING 1 0.0000
223 INFECTION 1 0.0000
224 OFF LABEL USE 6 0.0000
225 DRUG INEFFECTIVE 9 0.0000
226 ACUTE KIDNEY INJURY 1 0.0000
227 NAUSEA 5 0.0000
228 DEATH 5 0.0000
229 PYREXIA 2 0.0000
230 CHEST PAIN 1 0.0000
231 PRODUCT USE ISSUE 1 0.0000
232 GAIT DISTURBANCE 1 0.0000
233 ABDOMINAL PAIN UPPER 1 0.0000
234 HYPERTENSION 1 0.0000
235 ABDOMINAL PAIN 1 0.0000
236 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
237 DIZZINESS 2 0.0000
238 INSOMNIA 1 0.0000
239 WEIGHT DECREASED 1 0.0000
240 PAIN IN EXTREMITY 1 0.0000
241 CONDITION AGGRAVATED 1 0.0000
242 INJECTION SITE PAIN 1 0.0000
243 RASH 1 0.0000
244 MALAISE 1 0.0000
245 PAIN 1 0.0000